# Umlaut.bio

**Source:** https://www.startuphub.ai/startups/umlautbio
**Profile type:** Startup

> Developing novel immunotherapies for cancer.

## About

Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.

## Key facts

- **Slug:** umlautbio
- **Website:** https://www.umlaut.bio/
- **Location:** Cambridge, Massachusetts, USA
- **Founded:** 2022-01-01
- **Operating status:** Active
- **Total funding:** $3M
- **Sectors / tags:** Biotechnology, Cancer, Immunotherapy, Drug Discovery
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/umlautbio/

## Frequently asked

### What does Umlaut.bio do?

Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.

### What is Umlaut.bio's revenue?

StartupHub estimates Umlaut.bio's annual revenue at $232K (range $76K to $784K, 33% confidence), based on comparable companies in the sector.

### What is Umlaut.bio's valuation?

StartupHub estimates Umlaut.bio's effective valuation at $11.1M (range $7.5M to $18.0M, 22% confidence), based on comparable companies in the sector.

### How much funding has Umlaut.bio raised?

Umlaut.bio has raised a total of $3M in funding. The most recent round on record is Pre-Seed.

### Where is Umlaut.bio headquartered?

Umlaut.bio is headquartered in Cambridge, Massachusetts, USA.

### When was Umlaut.bio founded?

Umlaut.bio was founded in 2022.

### What industry does Umlaut.bio operate in?

Umlaut.bio operates in Biotechnology, Cancer, Immunotherapy, Drug Discovery.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Umlaut.bio",
          "item": "https://www.startuphub.ai/startups/umlautbio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/umlautbio#webpage",
      "url": "https://www.startuphub.ai/startups/umlautbio",
      "name": "Umlaut.bio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Umlaut.bio. Umlaut.bio is a startup founded in 2022, operating in Biotechnology and Cancer. Developing novel immunotherapies for cancer. Headquartered in Cambridge, Massachusetts, USA.",
      "dateModified": "2026-06-29T06:00:27.306+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/umlautbio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/umlautbio#organization",
      "name": "Umlaut.bio",
      "url": "https://www.umlaut.bio/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/umlautbio-square-from-og.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/umlautbio-square-from-og.webp",
      "description": "This is the official profile of Umlaut.bio. Umlaut.bio is a startup founded in 2022, operating in Biotechnology and Cancer. Developing novel immunotherapies for cancer. Headquartered in Cambridge, Massachusetts, USA.",
      "sameAs": [
        "https://www.linkedin.com/company/umlautbio/",
        "https://www.startuphub.ai/startups/umlautbio"
      ],
      "foundingDate": "2022-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "Massachusetts",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Cancer",
        "Immunotherapy",
        "Drug Discovery"
      ]
    }
  ]
}
```